These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31691527)

  • 21. EGFR inhibition in glioblastoma cells induces G2/M arrest and is independent of p53.
    Kapoor GS; Christie A; O'Rourke DM
    Cancer Biol Ther; 2007 Apr; 6(4):571-9. PubMed ID: 17457042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway.
    Yang R; Wu Y; Zou J; Zhou J; Wang M; Hao X; Cui H
    Oncotarget; 2016 Jun; 7(24):36255-36265. PubMed ID: 27167112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.
    Ramis G; Villalonga-Planells R; Serra-Sitjar M; Brell M; Fernández de Mattos S; Villalonga P
    Cell Oncol (Dordr); 2019 Aug; 42(4):521-536. PubMed ID: 30980364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
    Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
    Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microenvironmental stiffness enhances glioma cell proliferation by stimulating epidermal growth factor receptor signaling.
    Umesh V; Rape AD; Ulrich TA; Kumar S
    PLoS One; 2014; 9(7):e101771. PubMed ID: 25000176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
    Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S
    Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
    Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
    J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma.
    Zhang C; Han X; Xu X; Zhou Z; Chen X; Tang Y; Cheng J; Moazzam NF; Liu F; Xu J; Peng W; Du F; Zhang B; Song Z; Zeng J; Gong A
    Cell Death Dis; 2018 May; 9(5):469. PubMed ID: 29700308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
    Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
    Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
    Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH
    Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.
    Chen X; Huang L; Yang Y; Chen S; Sun J; Ma C; Xie J; Song Y; Yang J
    Aging (Albany NY); 2020 Jan; 12(1):224-241. PubMed ID: 31905171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
    Yadav N; Babu D; Madigubba S; Panigrahi M; Phanithi PB
    J Neurooncol; 2023 Jul; 163(3):675-692. PubMed ID: 37415005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
    Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
    Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model.
    Verreault M; Weppler SA; Stegeman A; Warburton C; Strutt D; Masin D; Bally MB
    PLoS One; 2013; 8(3):e59597. PubMed ID: 23555046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.
    Pinheiro KV; Thomaz A; Souza BK; Metcalfe VA; Freire NH; Brunetto AT; de Farias CB; Jaeger M; Bambini V; Smith CGS; Shaw L; Roesler R
    Mol Biol Rep; 2020 Sep; 47(9):6817-6828. PubMed ID: 32862352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway.
    Chen Y; Niu J; Li L; Li Z; Jiang J; Zhu M; Dong T; Zhang J; Shi C; Xu P; Lu Y; Jiang Y; Liu P; Chen W
    Life Sci; 2020 Oct; 258():118158. PubMed ID: 32750435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZC3H15 promotes glioblastoma progression through regulating EGFR stability.
    Hou J; Xu M; Gu H; Pei D; Liu Y; Huang P; Chang H; Cui H
    Cell Death Dis; 2022 Jan; 13(1):55. PubMed ID: 35027542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway.
    Liu Q; Xu X; Zhao M; Wei Z; Li X; Zhang X; Liu Z; Gong Y; Shao C
    Mol Cancer Ther; 2015 Feb; 14(2):355-63. PubMed ID: 25504754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
    Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
    Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.